BridgeMD
New treatment option for Arthroplasty Shoulder
Official title Optimizing Infection Prophylaxis Prior to Shoulder Surgery
ClinicalTrials.gov ID: NCT06464770
What this study is testing
What is Chlorhexidine Gluconate?
Chlorhexidine Gluconate is an investigational medicine, being studied as a potential treatment for arthroplasty shoulder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this interventional study is to determine the amount of skin C. acnes reduction with increased pressure during the chlorhexidine gluconate, brand name ChloraPrep, application.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89, men only. Healthy volunteers may be eligible.
You may be able to join if
- English speaking
You likely can't join if
- Self report very sensitive skin
- Allergic to chlorhexidine
- Used antibiotics in the last three months
- Used acne treatment in the last three months
- Wounds on your shoulders
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 89 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.